JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: We have recently identified an AHI-1-BCR-ABL-JAK2 protein complex that contributes to the transforming activity of BCR-ABL and IM-resistance in CML stem/progenitor cells.